Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum TWEAK Level in Psoriasis
NCT ID: NCT04811911
Last Updated: 2021-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
30 participants
INTERVENTIONAL
2020-12-13
2021-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum Chitotriosidase Level in Psoriasis
NCT05427175
Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin
NCT05203354
Effect of Acitretin Versus Narrowband Ultraviolet B on Neopterin Level in Psoriatic Patients .
NCT05401006
Evaluation The Effect of NB-UVB and Methotrexate on The Level of Serum Gelsolin in Psoriatic Patients
NCT06712238
Methotrexate Alone vs Combination With Excimer Light in Nail Psoriasis
NCT06150794
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Narrowband ultraviolet B
Patients will receive 8 sessions of NB-UVB per month for 3 successive months
Narrowband ultraviolet B
Patients will receive 8 sessions of NB-UVB per month for 3 successive months
Methotrexate group
Patients will receive 25 mg/1ml of methotrexate vial per week for 3 successive months
Methotrexate
Patients will receive 25 mg/1ml of methotrexate vial per week for 3 successive months
healthy individuals as control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Narrowband ultraviolet B
Patients will receive 8 sessions of NB-UVB per month for 3 successive months
Methotrexate
Patients will receive 25 mg/1ml of methotrexate vial per week for 3 successive months
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnancy and lactation.
* Infections
* Patients with chronic diseases: hepatic disorders, hematologic disease, chronic renal failure or cancer
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aswan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
El Hassan Mohsen Mansour Mahmoud
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Moustafa A El Taieb, Professor
Role: STUDY_CHAIR
Faculty of medicine aswan university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aswan University - Faculty of Medicine
Aswān, Aswan Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
498/12/20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.